Investing in Balaxi Pharma: A Comprehensive Analysis of Share Price

Investing in pharmaceutical companies has been witnessing a rapid increase in numbers after the budget 2024 announcements of deducting funds for pharmaceutical development. 

 If you are exploring the sector, you must have come across the name Balaxi Pharma as they are a leading name in the industry with rather interesting share price movements over the years. 

Please keep reading to understand more about the company as we analyse Balaxi Pharma Share Price movements to help you make an informed choice.

Balaxi Pharma- Company Overview

In 1942 a company named The Anandam Rubber Company Ltd. was started that changed its name in 2020 to become Balaxi Pharmaceuticals Ltd. Over the years they have acquired several rubber and tea plantations, emerged as a leading investment company and shifted towards providing high-quality everyday medicines. 

 The company has a rich product portfolio with over 610 pharmaceutical products and with geographical presence in countries like Angola, Dominican Republic, and Guatemala. The present market cap of the company stands at ₹594 crores with its share price standing at ₹ 107.61 as of 30th August, 2024. 1 

Balaxi Pharma Share Price: Viewing  Price Movements 

Talking about their stand in the stock market it is safe to say that they have seen ups and downs for a larger part of their existence, however in recent years the company has marked a downward movement. For instance:

• The company’s sales were down by 24.02% year to year, as of August 2024. 

• The EPS witnessed a decrease from ₹2.50 to ₹0.25 

• Additionally, in the last three months, their stocks have moved down by -21.6%. 1

Let’s take a detailed look at the company’s Q1 FY 2024-2025 results for a better understanding:

• Revenue– Their revenue has fallen by -1.8% compared to the last year and has generated only a 7.83% jump in the last three months. 

• Net Profits– Their net profits have seen a jump of 115.67% as compared to the same time last year. 1

Balaxi Pharma Share Prices: A Quick Look at Peer Comparison Table

Here’s a table of peer comparison to help you get an overview of the pharma sector in the stock market: 

What does the Future for Balaxi Pharma

As a new financial year unfolds, there are expectations of a positive movement in the company’s share prices, especially with retail investors increasing their holding from 16.54% to 17.11% in June 2024.

Their commitment to geographical and product expansion has appeared to be a saving grace to overcome the adversities.

They have expanded their product registration to reach an impressive number of 960. For future developments, the company has laid the groundwork by establishing operations in new markets like Honduras, El Salvador, and Nicaragua. 

The company’s push for green initiatives, societal responsibility and a robust investor relation keeps the hope up. Additionally, what makes them stand apart as a futurist company is the focus on factors like:

• Intellectual Property Rights 

• Infrastructure and Distribution Strength

• Product Registration

• Asset-Light Production

The Bottom Line

Investing in a company like Balaxi Pharma can have promising results given the company’s vision for a sustainable future and social responsibility. While the recent share prices have witnessed a shaky movement, experts are expecting a revival shortly.

However, before choosing to invest in a company it is advised to perform due diligence by reading charts, updated news and events. Additionally, to Open Demat Account online with a credible portal like Bajaj Trading can provide a seamless and quick investment experience.